Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Caccese

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.
Anti-Cancer Drugs|November 9, 2019
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabMario Caccese, Mattia Barbot, Filippo Ceccato, et al.
Anti-Cancer Drugs|August 7, 2018
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two casesGiuseppe Lombardi, Mario Caccese, Luisa Bellu, et al.
Cancers|July 2, 2021
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)Marta Padovan, Marica Eoli, Alessia Pellerino, et al.
Cancer Medicine|December 30, 2022
Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?Mario Caccese, Anna Maria Saieva, Valentina Guarneri, et al.
Cancers|August 26, 2022
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team EvaluationIrene Tizianel, Mario Caccese, Francesca Torresan, et al.
International Journal of Molecular Sciences|September 17, 2020
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter StudyMario Caccese, Tamara Ius, Matteo Simonelli, et al.
Critical Reviews in Oncology/Hematology|July 28, 2020
Anaplastic Astrocytoma: State of the art and future directionsMario Caccese, Marta Padovan, Domenico D'Avella, et al.
Oncology Letters|July 31, 2024
Local therapy in glioma: An evolving paradigm from history to horizons (Review)Tamara Ius, Teresa Somma, Francesco Pasqualetti, et al.
Future Science OA|December 30, 2016
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case reportChiara Ciccarese, Roberto Ferrara, Emanuela Fantinel, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Expert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.
Anti-Cancer Drugs|November 9, 2019
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabMario Caccese, Mattia Barbot, Filippo Ceccato, et al.
Anti-Cancer Drugs|August 7, 2018
Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two casesGiuseppe Lombardi, Mario Caccese, Luisa Bellu, et al.
Cancers|July 2, 2021
Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)Marta Padovan, Marica Eoli, Alessia Pellerino, et al.
Cancer Medicine|December 30, 2022
Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?Mario Caccese, Anna Maria Saieva, Valentina Guarneri, et al.
Cancers|August 26, 2022
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team EvaluationIrene Tizianel, Mario Caccese, Francesca Torresan, et al.
International Journal of Molecular Sciences|September 17, 2020
Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter StudyMario Caccese, Tamara Ius, Matteo Simonelli, et al.
Critical Reviews in Oncology/Hematology|July 28, 2020
Anaplastic Astrocytoma: State of the art and future directionsMario Caccese, Marta Padovan, Domenico D'Avella, et al.
Oncology Letters|July 31, 2024
Local therapy in glioma: An evolving paradigm from history to horizons (Review)Tamara Ius, Teresa Somma, Francesco Pasqualetti, et al.
Future Science OA|December 30, 2016
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case reportChiara Ciccarese, Roberto Ferrara, Emanuela Fantinel, et al.
Pageof 6